Real-time T-cell profiling identifies H60 as a major minor histocompatibility antigen in murine graft-versus-host disease
- PMID: 12393464
- DOI: 10.1182/blood-2002-05-1299
Real-time T-cell profiling identifies H60 as a major minor histocompatibility antigen in murine graft-versus-host disease
Abstract
Although CD8 T cells are thought to be a principal effector population of graft-versus-host disease (GVHD), their dynamics and specificity remain a mystery. Using a mouse model in which donor and recipient were incompatible at many minor histocompatibility antigens (minor H Ags), the CD8 T-cell response was tracked temporally and spatially through the course of GVHD. Donor CD8 T cells in the circulation, spleen, lung, and liver demonstrated virtually identical kinetics: rapid expansion and then decline prior to morbidity. Remarkably, up to one fourth of the CD8 T cells were directed against a single minor antigen, H60. Extreme H60 immunodominance occurred regardless of sampling time, site, and genetic background. This study is the first to analyze the T cells participating in GVHD in "real-time," demonstrates the exceptional degree to which immunodominance of H60 can occur, and suggests that such superdominant minor H Ags could be risk factors for GVHD.
Similar articles
-
Quantitative analysis of the immune response to mouse non-MHC transplantation antigens in vivo: the H60 histocompatibility antigen dominates over all others.J Immunol. 2001 Apr 1;166(7):4370-9. doi: 10.4049/jimmunol.166.7.4370. J Immunol. 2001. PMID: 11254691
-
T cell subsets involved in lethal graft-versus-host disease directed to immunodominant minor histocompatibility antigens.Transplantation. 1994 Apr 15;57(7):1095-102. Transplantation. 1994. PMID: 7909395
-
Graft-versus-host disease impairs vaccine responses through decreased CD4+ and CD8+ T cell proliferation and increased perforin-mediated CD8+ T cell apoptosis.J Immunol. 2013 Feb 1;190(3):1351-9. doi: 10.4049/jimmunol.1200391. Epub 2012 Dec 28. J Immunol. 2013. PMID: 23275602 Free PMC article.
-
Biology of graft-vs.-host disease.Am J Pediatr Hematol Oncol. 1993 Feb;15(1):18-27. doi: 10.1097/00043426-199302000-00003. Am J Pediatr Hematol Oncol. 1993. PMID: 8447559 Review.
-
H60: A Unique Murine Hematopoietic Cell-Restricted Minor Histocompatibility Antigen for Graft-versus-Leukemia Effect.Front Immunol. 2020 Jun 10;11:1163. doi: 10.3389/fimmu.2020.01163. eCollection 2020. Front Immunol. 2020. PMID: 32587590 Free PMC article. Review.
Cited by
-
Enhancement of Antigen Presentation by Deletion of Viral Immune Evasion Genes Prevents Lethal Cytomegalovirus Disease in Minor Histocompatibility Antigen-Mismatched Hematopoietic Cell Transplantation.Front Cell Infect Microbiol. 2020 Jun 9;10:279. doi: 10.3389/fcimb.2020.00279. eCollection 2020. Front Cell Infect Microbiol. 2020. PMID: 32582572 Free PMC article.
-
Remodeling specific immunity by use of MHC tetramers: demonstration in a graft-versus-host disease model.Blood. 2006 Mar 1;107(5):2045-51. doi: 10.1182/blood-2005-07-2828. Epub 2005 Nov 3. Blood. 2006. PMID: 16269613 Free PMC article.
-
Major and minor histocompatibility antigens to NIMA: Prediction of a tolerogenic NIMA effect.Chimerism. 2011 Jan;2(1):23-4. doi: 10.4161/chim.2.1.15127. Chimerism. 2011. PMID: 21547034 Free PMC article.
-
Establishment of a murine graft-versus-myeloma model using allogeneic stem cell transplantation.PLoS One. 2014 Nov 21;9(11):e113764. doi: 10.1371/journal.pone.0113764. eCollection 2014. PLoS One. 2014. PMID: 25415267 Free PMC article.
-
Studies on the antigenicity of the NKG2D ligand H60a in tumour cells.Immunology. 2011 Jun;133(2):197-205. doi: 10.1111/j.1365-2567.2011.03427.x. Epub 2011 Mar 25. Immunology. 2011. PMID: 21438873 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials